By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PharmaCyte Biotech (Formerly Known As Nuvilex) 

1971 Old Cuthbert Road

Cherry Hill  New Jersey  08034  U.S.A.
Phone: 856-433-6088 Fax: 856-354-1077



Company News
PharmaCyte Biotech (NVLX) On Track to Commence Clinical Trials 3/27/2015 12:41:48 PM
PharmaCyte Biotech (NVLX) Provides Update On Corporate Developments And Progress With Cancer And Diabetes Programs 3/16/2015 7:21:17 AM
PharmaCyte Biotech (NVLX) Announces Launch Of New Corporate Website 3/10/2015 7:42:48 AM
PharmaCyte Biotech (NVLX)'s Scientific Advisory Board Chairman Publishes Review Article On The Pathology Of Pancreatic Cancer 2/24/2015 10:40:31 AM
Nuvilex Announces Name Change To PharmaCyte Biotech (NVLX) 1/7/2015 10:02:57 AM
Nuvilex (NVLX) To Attend 2015 Gastrointestinal Cancers Symposium In San Francisco, January 15-17, 2015 1/6/2015 10:06:22 AM
FDA Grants Orphan Drug Designation To Nuvilex (NVLX) For Pancreatic Cancer Treatment 12/22/2014 7:25:23 AM
Nuvilex (NVLX)'s Partner Austrianova Successfully Completes First Live Cell Encapsulation In New Facility 12/18/2014 8:08:46 AM
Nuvilex (NVLX) Provides Shareholder Update On Cancer And Diabetes Programs 12/16/2014 7:58:24 AM
Nuvilex (NVLX) Provides Update On Significance Of Austrianova's cGMP Live-Cell Encapsulation Facility 12/11/2014 7:31:37 AM